Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Unearned ESOP Shares	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023		11,208,500
Beginning balance at Dec. 31, 2023	$ 134,859,576	$ 112,085	$ 101,347,566	$ 87,902,747	$ (11,457,726)	$ (43,045,096)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	6,901,373			6,901,373
Other comprehensive (loss) income	4,074,892					4,074,892
ESOP shares earned	476,482		(75,005)		551,487
Forfeiture of restricted stock awards (in shares)		(400)
Forfeiture of restricted stock awards	0	$ (4)	4
Stock based compensation	1,102,526		1,102,526
Exercise of stock options (in shares)		1,952
Exercise of stock options	(13)	$ 19	(32)
Common stock dividends	(4,293,077)			(4,293,077)
Repurchase of common stock (in shares)		(261,234)
Repurchase of common stock	(3,095,162)	$ (2,612)	(3,092,550)
Ending balance (in shares) at Sep. 30, 2024		10,948,818
Ending balance at Sep. 30, 2024	140,026,597	$ 109,488	99,282,509	90,511,043	(10,906,239)	(38,970,204)
Beginning balance (in shares) at Jun. 30, 2024		11,018,824
Beginning balance at Jun. 30, 2024	131,110,254	$ 110,188	99,813,232	89,457,837	(11,090,068)	(47,180,935)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,471,878			2,471,878
Other comprehensive (loss) income	8,210,731					8,210,731
ESOP shares earned	166,755		(17,074)		183,829
Stock based compensation	371,537		371,537
Exercise of stock options (in shares)		1,300
Exercise of stock options	(11)	$ 13	(24)
Common stock dividends	(1,418,672)			(1,418,672)
Repurchase of common stock (in shares)		(71,306)
Repurchase of common stock	(885,875)	$ (713)	(885,162)
Ending balance (in shares) at Sep. 30, 2024		10,948,818
Ending balance at Sep. 30, 2024	$ 140,026,597	$ 109,488	99,282,509	90,511,043	(10,906,239)	(38,970,204)
Beginning balance (in shares) at Dec. 31, 2024	10,814,960	10,814,960
Beginning balance at Dec. 31, 2024	$ 132,871,760	$ 108,150	97,709,231	91,582,986	(10,722,410)	(45,806,197)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	8,167,314			8,167,314
Other comprehensive (loss) income	7,699,403					7,699,403
ESOP shares earned	552,460		972		551,488
Granting of restricted stock awards (in shares)		37,126
Granting of restricted stock awards	0	$ 372	(372)
Stock based compensation	$ 756,213		756,213
Exercise of stock options (in shares)	0
Common stock dividends	$ (4,378,315)			(4,378,315)
Repurchase of common stock (in shares)		(425,823)
Repurchase of common stock	$ (5,633,659)	$ (4,259)	(5,629,400)
Ending balance (in shares) at Sep. 30, 2025	10,426,263	10,426,263
Ending balance at Sep. 30, 2025	$ 140,035,176	$ 104,263	92,836,644	95,371,985	(10,170,922)	(38,106,794)
Beginning balance (in shares) at Jun. 30, 2025		10,389,137
Beginning balance at Jun. 30, 2025	132,321,565	$ 103,891	92,798,702	93,220,564	(10,354,751)	(43,446,841)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,597,006			3,597,006
Other comprehensive (loss) income	5,340,047					5,340,047
ESOP shares earned	192,849		9,020		183,829
Granting of restricted stock awards (in shares)		37,126
Granting of restricted stock awards	0	$ 372	(372)
Stock based compensation	29,294		29,294
Common stock dividends	$ (1,445,585)			(1,445,585)
Ending balance (in shares) at Sep. 30, 2025	10,426,263	10,426,263
Ending balance at Sep. 30, 2025	$ 140,035,176	$ 104,263	$ 92,836,644	$ 95,371,985	$ (10,170,922)	$ (38,106,794)